Building on the success of this year’s inaugural Crohn’s & Colitis Congress™, the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are pleased to announce the second annual Crohn’s & Colitis Congress. Be sure to save the date.
February 7-9, 2019 at the Bellagio in Las Vegas
Gain a multidisciplinary perspective on treating IBD. Join IBD health care professionals to network, learn from each other, and collaborate in transforming IBD patient care.
By bringing all audiences together to learn from each other, the Congress embodies how IBD research and patient care needs to be approached – it is not “one-size-fits-all” and it requires collaboration from a variety of health practitioners.
Be sure to visit this website in the future for more details. Registration will open on June 27, 2018
If you attended the 2018 Crohn’s & Colitis Congress, you can continue to use the mobile app after the meeting to view session presentations (that presenters agreed to publish), abstracts and more.
To claim CME for the Congress, please complete the CME Request Form. Your CME certificate will be emailed to you within a week of completing the form.
The Crohn's & Colitis Congress is supported by educational grants from AbbVie Inc., Celgene Corporation, Gilead Sciences, Inc., Merck & Co., Inc., Nestlé Health Science, Pfizer, Salix Pharmaceuticals, Shire Plc. and Takeda Pharmaceuticals U.S.A., Inc.